REVB
Revelation Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.26
+0.03 ▲ +2.06%
🌙 3월 13일 7:25 PM ET (한국 3/14 08:25)
$1.25
+0.00 -0.40%
| Index | - | P/E | - | EPS (ttm) | -62.1 | Insider Own | 56.11% | Shs Outstand | 0.00B | Perf Week | -2.69% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 20.7% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -16.31% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -1.15 | Inst Own | 8.27% | Short Float | 0.8% | Perf Quarter | -71.21% |
| Income | -0.01B | P/S | - | EPS this Y | 82.65% | Inst Trans | 6.86% | Short Ratio | 0.02 | Perf Half Y | -84.31% |
| Sales | 0.00B | P/B | 0.22 | EPS next 5Y | - | ROA | -97.93% | Short Interest | 0.01M | Perf YTD | -60.76% |
| Book/sh | 5.59 | P/C | 0.44 | EPS past 3/5Y | 94.09% 76.86% | ROE | -131.38% | 52W High | -97.2% ($44.77) | Perf Year | -96.8% |
| Cash/sh | 2.88 | P/FCF | - | Sales past 3/5Y | - | ROIC | -155.09% | 52W Low | 5.49% ($1.19) | Perf 3Y | -99.99% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 96.3% | Gross Margin | - | Volatility(W/M) | 8.01% 7.23% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.15 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.41 | EPS Q/Q | 97.24% | Profit Margin | - | RSI (14) | 31.21 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.41 | Sales Q/Q | - | SMA20 | -5.81% ($1.34) | Beta | -0.16 | Target Price | $53 |
| Payout | - | Debt/Eq | 0.08 | Earnings | 2000000 | SMA50 | -41.28% ($2.15) | Rel Volume | 0.12 | Prev Close | $1.23 |
| Employees | 8 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | 54.92% - | SMA200 | -79.84% ($6.25) | Avg Volume(3M) | 0.66M | Price | $1.26 |
| IPO | 2020/11/17 | Option/Short | No/Yes | Trades | 329 | Volume | 78,429 | Change | 2.06% |
뉴스 로딩 중...